Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also ...

Lyndra Therapeutics®, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the ...

The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembotm Embolic System. The Tembo ...

The Protein Sequencing Companytm, and IDEX Health & Science, LLC., today announced they will partner on the development and manufacturing of the optics module for Quantum-Si's ...

His past board memberships include Lyndra Therapeutics. He holds a Bachelor of Science degree from Union University, an MBA from the University of Chicago, and was named a Pew Scholar. Equitable ...

Lee is survived by his children, Dixie and Dalton Cash; his one brother Donnie Dayries (Donna); his three sisters Lisa Dayries Womack (Ron), Lyndra Dayries Strickland (Paul), and DeAnn Dayries ...

Mr. Dachille currently serves as an independent director of the BridgeBio Pharma, Inc. Board of Directors and previously served on the board of directors for Lyndra Therapeutics®. He earned a ...